Global Empty Capsule Industry Surging to a Remarkable US$4.9 Billion with a Striking 7.9% CAGR by 2033 | FMI Findings

Recent market projections have unveiled a highly promising future for the Global Empty Capsules Industry, marking a significant era of growth and market expansion. Industry reports indicate that sales in the Global Empty Capsules sector are poised to reach an impressive US$2.3 Billion in 2023, foreshadowing an optimistic outlook for the years ahead.

The industry's upward trajectory is underscored by a projected Compound Annual Growth Rate (CAGR) of 7.9% from 2023 to 2033. This sustained growth is expected to lead to a remarkable valuation of US$4.9 Billion by 2033, showcasing the industry's resilience and its ability to adapt to the evolving demands of the global market.

Driving Factors Behind Surging Demand for Empty Capsules

The primary drivers behind the surging demand for empty capsules are twofold. First, there is a noticeable uptick in the popularity of capsules as the preferred form of drug delivery. This shift is further accentuated by the increasing consumption of various medications. Secondly, as the global burden of chronic diseases continues to escalate, the demand for effective therapeutics is expected to surge, presenting lucrative opportunities for suppliers of empty capsules.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-782

The Advantages of Capsule-Based Drug Delivery Systems

Moreover, the shift towards capsule-based drug delivery systems can be attributed to their several advantages, including improved bioavailability, better patient compliance, and enhanced efficacy. These benefits have significantly contributed to the growing preference for capsules among both patients and healthcare professionals. As a result, the demand for empty capsules is on a continuous rise.

A Promising Future for the Global Empty Capsules Industry

In summary, the future of the Global Empty Capsules Industry appears incredibly promising, with robust growth prospects anticipated in the years ahead. Key industry players operating in the market are well-positioned to benefit from this trend, provided they adapt to evolving consumer preferences and invest in product innovation to maintain a competitive edge.

Empty capsules are known as protective shells for drugs designed from special film-forming materials such as gelatin, starch, and pullulan. Being innovative drug delivery products, they are utilized by leading pharmaceutical and biopharmaceutical companies due to their various attractive features. Such capsules are economical, oxidation resistant, offer maximum flexibility, and are easy to use on account of their smooth and slippery nature. Furthermore, they are especially suitable for substances having a bitter taste and unpleasant odor.

Key Takeaways

• With a market share of more than 38.3%, North America now dominates the global empty capsules industry.
• Western Europe and Eastern Europe currently have market shares of more than 18.8% and 7.8%, respectively.
• Latin America is expected to develop significantly throughout the projected period, accounting for more than 9.7% of the Global Empty Capsules Industry.
• The German empty capsules market is committed to the region’s growth. The German market is expected to reach US$ 269.6 million by 2033, growing at a CAGR of 7.9% in the interim.
• Gelatin-based capsules, particularly 00 gelatin capsules, 000 gelatin capsules, size 5 gelatin capsules, and size 3 gelatin capsules, are expected to grow in popularity until 2033.
• In recent years, there has been a significant growth in the consumption of nutraceuticals to strengthen immunity and compensate for the nutrition lost owing to poor eating habits and the irregularity of a sedentary lifestyle.

Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-782

Competitive Landscape

The Global Empty Capsules Industry is known to be highly competitive attributed to the presence of leading empty pill manufacturers that account for over 70% of the global market share. Prominent market players are constantly focusing on introducing new products designed out of innovative materials. In addition to that, they are adopting growth strategies such as partnerships, mergers, acquisitions, etc. to expand their global footprint.

List encompassing key players operating in the Global Empty Capsules Industry

• ACG Worldwide
• Capsugel
• Qualicaps Inc.
• Bright Pharma Caps Inc.
• Sunil Healthcare Ltd.
• CapsCanada Corporation
• Roxlor LLC
• Snail Pharma Industry Co. Ltd.
• Suheung Co. Ltd.
• Medi-Caps Ltd

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/782

Key Segments of Empty Capsules Industry Survey

Capsule Size:

• Size “000” Empty Capsules
• Size “00” Empty Capsules
• Size “0” Empty Capsules
• Size “1” Empty Capsules
• Size “2” Empty Capsules
• Size “3” Empty Capsules
• Size “4” Empty Capsules
• Size “5” Empty Capsules

Product Type:

• Gelatin (Hard)-based Capsules
• Vegetarian-based Capsules

Route of Administration:

• Empty Capsules for Oral Administration
• Empty Capsules for Inhalation

Raw Material:

• Contract Type-A (Pork Skin) Empty Capsules
• Type-B Gelatin (Animal Bones & Calf Skin) Empty Capsules
• Fish Bone Gelatin Empty Capsules
• Empty Hydroxy Propyl Methyl Cellulose (HPMC) Empty Capsules
• Starch Material Empty Capsules
• Empty Pullulan Capsules

End User:

• Empty Capsules for Pharmaceutical Companies
• Empty Capsules for Cosmetic & Nutraceutical Companies
• Empty Capsules for Clinical Research Organizations (CROS)

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.